Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

gemtuzumab ozogamicin

View Patient Information
A recombinant, humanized anti-CD33 monoclonal antibody attached to the cytotoxic antitumor antibiotic calicheamicin. In this conjugate, the antibody binds to and is internalized by tumor cells expressing CD33 antigen (a sialic acid-dependent glycoprotein commonly found on the surface of leukemic blasts), thereby delivering the attached calicheamicin to CD33-expressing tumor cells. Calicheamicin binds to the minor groove of DNA, causing double strand DNA breaks and resulting in inhibition of DNA synthesis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:Calicheamicin-Conjugated Humanized Anti-CD33 Monoclonal Antibody
hP67.6-Calicheamicin
US brand name:Mylotarg
Code name:CDP-771
CMA-676
WAY-CMA-676
NSC code:720568
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search